Initial report of laparoscopic single incision plus one port with simultaneous robotic-assisted transanal total mesorectal excision for low rectal cancer surgery
10.3760/cma.j.cn.441530-20190508-00203
- VernacularTitle:单孔加一孔腹腔镜经腹同步联合机器人经肛全直肠系膜切除术在低位直肠癌手术中的初步应用
- Author:
Dewen TAN
1
;
Fan ZHANG
;
Jingwang YE
;
Zhengyong LIU
;
Zhigang KE
;
Ran LI
;
Weidong TONG
;
Fan LI
Author Information
1. 陆军军医大学大坪医院普通外科，重庆 400042
- Keywords:
Rectal neoplasms, Low position;
Total mesorectal excision, trananal, transabdominal;
Robotic surgery;
Laparoscopic surgery, Single incision plus one port
- From:
Chinese Journal of Gastrointestinal Surgery
2020;23(6):605-609
- CountryChina
- Language:Chinese
-
Abstract:
Robotic-assisted transanal total mesorectal excision (R-TaTME) has unique advantage in low rectal cancer. Single incision plus oneport (SIPOP) laparoscopic operation can synchronously cooperate with robotic-assisted transanal operation, in order to the difficulty of operation, improve the quality of operation and shorten the time of operation. A retrospective analysis was conducted on the clinical and pathological data of one patient who underwent SIPOP synchronously combined with R-TaTME + sigmoid-anal anastomosis + ileostomy at the Department of General Surgery, Army Characteristic Medical Center on September 11, 2019. This 71-year-old patient was male with body mass index of 24.08 kg/m 2 and received preoperative chemotherapy. Rectal adenocarcinoma was confirmed by colonoscopy biopsy, and distance from tumor lower edge to anal verge was 3 cm. MRI indicated T2N1 stage. The operation was completed successfully, and the transabdominal and robotic transanal surgery totaled 117 minutes, with 15 minutes for the robotic transanal preparation step. There was about 20 ml of intraoperative blood loss and no blood transfusion was performed. The patient was discharged 6 days after operation. No intraoperative or postoperative complications occurred. The postoperative TNM staging was stage I (pyT2N0cM0). No recurrence or metastasis was found at postoperative 7 month. It is a safe, effective and feasible technique for patients with low rectal cancer.
